FDA Inspection 1165594 — University of Texas MD Anderson Cancer Center
The FDA completed an inspection of University of Texas MD Anderson Cancer Center on March 24, 2022 in Houston, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 24, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Houston, TX (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1454 | 21 CFR 211.115(a) | Reprocessing procedures not written or followed |